Viking TherapeuticsVKTX 
$42.350.07%24h
0.07%24h
Global rank2989
Market cap$4.00B
Change 7d-16.44%
YTD Performance-
SP500 benchmark
P/E-46.54
P/S0
Revenue$0
Earnings-$85.89M
Dividend yield-
Main Sector
Healthcare
Category
EPS for Viking Therapeutics (VKTX)
Viking Therapeutics has an EPS of $-0.91. In 2022, the company made an earnings per share (EPS) of $-0.9. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for VKTX
-
Value:-
EPS history for Viking Therapeutics from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$0.91 | 1.11% |
| 2022 | -$0.9 | 26.76% |
| 2021 | -$0.71 | 31.48% |
| 2020 | -$0.54 | - |
View the highest EPS stocks
